Comparison Study for Iron Deficiency Anemia Treatment Yields Positive Results

Article

The study’s results reveal that ferric maltol may offer efficiency and improved Hb levels for those with anemia.

Ferric maltol (Feraccru) met its primary endpoint when compared with ferric carboxymaltose (Ferinject, Daiichi-Sankyo), and delivered a hemoglobin (Hb) response rate at 12 weeks, which was within 9% of the effect seen with a market leading IV iron treatment (IVI FCM), according to a news release from Shield Therapeutics and Norvine BV. The novel oral iron replacement therapy was efficiently absorbed and well tolerated during the treatment period.

In the study, the oral medication ferric maltol demonstrated increases in Hb levels similar to that of IV ferric carboxymaltose. Current oral iron treatments can be poorly tolerated and ineffective, which can contribute to patients needing IV iron in hospital. However, ferric maltol’s potency means that patients with iron deficiency anemia (IDA) may have a long-term and well tolerated alternative treatment option so as to bypass time consuming and expensive hospital administration like IV.

Shield’s preliminary results for 2018 will be presented in early April 2019. This presentation will include such as secondary endpoints and safety parameters. The full data will be submitted for peer-review and subsequent presentation.

A New Drug Application in the USA is being reviewed by the FDA with a PDUFA date of 27 July 2019.

Reference

Important new trial with oral FERACCRU shows comparable efficacy to IV iron (ferric carboxymaltose), offering a real alternative to Hospital Administration for Many patients [news release]. Amsterdam, Netherlands. Published March 4, 2019. https://markets.businessinsider.com/news/stocks/important-new-trial-with-oral-feraccru-shows-comparable-efficacy-to-iv-iron-ferric-carboxymaltose-offering-a-real-alternative-to-hospital-administration-for-many-patients-4-1028000557. Accessed March 4, 2019.

Related Videos
Image credit:  Gorodenkoff | stock.adobe.com
Sun Screen, Photosensitivity, Pharmacy | Image Credit: sosiukin - stock.adobe.com
Catalyst Trial, Diabetes, Hypertension | Image Credit: grinny - stock.adobe.com
Various healthy foods -- Image credit: New Africa | stock.adobe.com
LGBTQIA+ pride -- Image credit: lazyllama | stock.adobe.com
Modern pharmacy building facade with large window showcasing the interior, as seen from the street view, promoting a welcoming atmosphere for customers. Frontal view. Generative AI - Image credit: Karrrtinki | stock.adobe.com
Close up hands of helping hands elderly home care. Mother and daughter. Mental health and elderly care concept - Image credit:  ipopba | stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.